Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Angler101on Jun 18, 2023 2:23pm
89 Views
Post# 35502559

RE:RE:RE:RE:RE:Roche CD47 antibody start-up gives up-lays off all employees

RE:RE:RE:RE:RE:Roche CD47 antibody start-up gives up-lays off all employeesHey Fox!....cmon man!......what’s going on....you ok?......most of us are supposed to be on the same side here!......why you pickin on Notable?......I know you’re getting anxious...so is everybody else....but our time is coming....and I believe it’s coming sooner than you think.....but pickin on Notable ain’t gonna make it come any sooner, mate!.....with all due respect, Fox, can’t you see that a company developing a product for market, and bleeding millions in the process is worth far less that one on the very cusp of assuring that product is going to be put on the market?.....the market is made up largely of buyers that want profit on their investments to happen right away.....they see a company like oncy and lick their lips contemplating its potential for profit, BUT, still don’t buy into it until they’re sure they’re going to see immediate gains on their investment.....in the meantime, their money is invested elsewhere where they ARE getting immediate gains.....but every day, we tick closer to that time when a deal is going to be reached, and the word will leak out beforehand, rumours will spread, the volume will increase like we saw the beginnings of last week, and we’re going to see the stock go to 3 bucks and then 5, and then eventually double digits and beyond.....and then all this worrying and freakin out you’re doing about the share price will have passed behind us......cmon man!.....I hope you’re ok, but chill out a little, Fox, relax and turn on the final round of the US Open.....patience grasshopper!.....our time is nearly upon us, Amigo!
<< Previous
Bullboard Posts
Next >>